Clinical Assessment and Management in Improving the Quality of Life of HIV/AIDS Patients with Oral Candidiasis: A Case Series

References

• Neville BW, Damm DD, Allen CM, et al. Color Atlas of Oral and Maxillofacial Diseases. Elsevier Inc; 2019.
   Google Scholar
• Caputo V, Libera M, Sisti S, Giuliani B, Diotti RA, Criscuolo E. The initial interplay between HIV and mucosal innate immunity. Front Immunol. 2023;14:1–18. doi:10.3389/fimmu.2023.1104423
   Web of Science ®Google Scholar
• Moyes DL, Richardson JP, Naglik JR. Candida albicans-epithelial interactions and pathogenicity mechanisms: scratching the surface. Virulence. 2015;6(4):338–346. doi:10.1080/21505594.2015.1012981
   PubMed Web of Science ®Google Scholar
• World Health Organization. Summary of the Global HIV Epidemic. Available from: https://www.who.int/data/gho/data/themes/hiv-aids. Accessed June 11, 2023.
   Google Scholar
• Cornea A, Lata I, Simu M, Rosca EC. Assessment and diagnosis of HIV-associated dementia. Viruses. 2023;15(2):1–23. doi:10.3390/v15020378
   Web of Science ®Google Scholar
• World Health Organization (WHO). Indonesia HIV Country Profile 2022; 2022. Available from: https://cfs.hivci.org/index.html. Accessed October 22, 2023.
   Google Scholar
• Rajendran R. Shafer’s Textbook of Oral Pathology. Elsevier Inc.; 2016.
   Google Scholar
• Lomelí-Martínez SM, González-Hernández LA, Ruiz-Anaya A, et al. Oral manifestations associated with HIV/AIDS Patients. Medicina. 2022;58(9). doi:10.3390/medicina58091214
   PubMedGoogle Scholar
• Putranti A, Asmarawati TP, Rachman BE, Hadi U. Oral candidiasis as clinical manifestation of HIV/AIDS infection in Airlangga University hospital patients. IOP Conf Ser Earth Environ Sci. 2018;125(1):012063. doi:10.1088/1755-1315/125/1/012063
   Google Scholar
• Aitken-Saavedra J, Dos Santos BC, Uchoa Vasconcellos AC, Flores DP, Maturana-Ramirez A. Oral lesions diagnosis associated with HIV. Report of 3 clinical cases. Rev Estomatol Hered. 2021;31(2):140–145. doi:10.20453/reh.v31i2.3975
   Google Scholar
• Farah C, Balasubramaniam R, Mccullough MJ. Contemporary Oral Medicine. Springer Nature; 2019; doi:10.1007/978-3-319-72303-7
   Google Scholar
• Mensana MP, Ernawati DS, Nugraha AP, et al. Oral candidiasis profile of the Indonesian HIV-infected pediatric patients at UPIPI Dr. Soetomo General Hospital, Surabaya, Indonesia. HIV AIDS Rev. 2018;17(4):272–277. doi:10.5114/hivar.2018.80259
   Web of Science ®Google Scholar
• Keser G, Namdar Pekiner F. Treatment approach for oral candidiasis: two case reports. Clin Exp Heal Sci. 2021;11:371–374. doi:10.33808/clinexphealthsci.862928
   Web of Science ®Google Scholar
• Rahardjo TM, Sumarlie BO, Kho EK, et al. Severe dehydration due to low intake in patients with oral candidiasis in malignancy: a case report. Med Clin Updat. 2023;2(1):62–65. doi:10.58376/mcu.v2i1.36
   Google Scholar
• Taverne-Ghadwal L, Kuhns M, Buhl T, et al. Epidemiology and prevalence of oral candidiasis in HIV patients from chad in the post-HAART Era. Front Microbiol. 2022;13. doi:10.3389/fmicb.2022.844069
   PubMed Web of Science ®Google Scholar
• Ongole R. Textbook of Oral Medicine, Oral Diagnosis and Oral Radiology. 2nd ed. Elsevier; 2013.
   Google Scholar
• Ratnawidya W, Rahmayanti F, Soegiyanto AI, Mandasari M, Wardhany II. Indonesian short version of the oral health impact profile (OHIP-14). J Int Dent MedRes. 2018;11(3):1065–1071.
   Google Scholar
• Jucá MACL, Silva LBD, Silva IAPD, Queiroga DEUD, Carvalho AMALD, Ferreira SMS. Impacts of health of users with HIV/AIDS in a specialized service. Rev Bras Enferm. 2019;72(6):1571–1579. doi:10.1590/0034-7167-2018-0649
   PubMed Web of Science ®Google Scholar
• Shrestha A, Rimal J, Poudyal N. CD4 count and oral health related quality of life of HIV-infected individuals at a tertiary healthcare center in Dharan – a cross-sectional study. J Coll Med Sci. 2017;13(4):392–396. doi:10.3126/jcmsn.v13i4.17808
   Google Scholar
• Yengopal V, Naidoo S. Do oral lesions associated with HIV affect quality of life?. Oral Surg Oral Med Oral Pathol Oral Radiol Endodontol. 2008;106(1):66–73. doi:10.1016/j.tripleo.2007.12.024
   PubMed Web of Science ®Google Scholar
• Sarangapany J, Batterham M, Begley K, et al. Application of oral health impact profile-14 on an HIV-1 infected population living in Sydney Method; 2009:2–3.
   Google Scholar
• Muralidharan S, Mahendrakar S, Talekar A, et al. Oral health-related quality of life in HIV: a systematic review. J Contemp Dent Pract. 2020;21(5):585–592. doi:10.5005/JP-JOURNALS-10024-2833
   PubMedGoogle Scholar
• Arbune M, Earar K, Brinduse LA. Assessment of dental status and oral health impact in HIV Romanian young adults. Mater Plast. 2016;53(1):3
   Web of Science ®Google Scholar
• Bhattarai D, Modak A, Suri D. Candidal perforation of the hard palate in an HIV-infected child. BMJ Case Rep. 2019;12(12):1–2. doi:10.1136/bcr-2019-233034
   Google Scholar
• Maheshwari M, Kaur R, Chadha S. Candida species prevalence profile in HIV seropositive patients from a Major Tertiary Care Hospital in New Delhi, India. J Pathog. 2016;2016:1–8. doi:10.1155/2016/6204804
   Google Scholar
• Lauritano D, Moreo G, Oberti L, et al. Oral manifestations in HIV-positive children: a systematic review. Pathogens. 2020;9(2):1–15. doi:10.3390/pathogens9020088
   Web of Science ®Google Scholar
• de Tilly AN, Tharmalingam S. Review of treatments for oropharyngeal Fungal infections in HIV/AIDS patients. Microbiol Res. 2022;13(2):219–234. doi:10.3390/microbiolres13020019
   Web of Science ®Google Scholar
• De Repentigny L, Lewandowski D, Jolicoeur P, et al. Immunopathogenesis of oropharyngeal candidiasis in human immunodeficiency virus infection. Clin Microbiol Rev. 2004;17(4):729–759. doi:10.1128/CMR.17.4.729-759.2004
   PubMed Web of Science ®Google Scholar
• Verma A, Gaffen SL, Swidergall M. Innate immunity to mucosal candida infections. J Fungi. 2017;3(4):1–15. doi:10.3390/jof3040060
   Web of Science ®Google Scholar
• Horváth M, Nagy G, Zsindely N, et al. Oral epithelial cells distinguish between candida species with high or low pathogenic potential through microRNA regulation. mSystems. 2021;6(3). doi:10.1128/msystems.00163-21
   PubMed Web of Science ®Google Scholar
• Groeger S, Meyle J, Diehl K, Bora SA, Cantorna MT. Oral mucosal epithelial cells. Front Immunol. 2019;10:1–22. doi:10.3389/fimmu.2019.00208
   PubMed Web of Science ®Google Scholar
• Vila T, Sultan AS, Montelongo-Jauregui D, Jabra-Rizk MA. Oral candidiasis: a disease of opportunity. J Fungi. 2020;6(1):1–28. doi:10.3390/jof6010015
   Web of Science ®Google Scholar
• Nikou SA, Kichik N, Brown R, et al. Candida albicans interactions with mucosal surfaces during health and disease. Pathogens. 2019;8(2):1–23. doi:10.3390/pathogens8020053
   Web of Science ®Google Scholar
• Sufiawati I, Tugizov SM. HIV-induced matrix metalloproteinase-9 activation through mitogen-activated protein kinase signalling promotes HSV-1 cell-to-cell spread in oral epithelial cells. J Gen Virol. 2018;99(7):937–947. doi:10.1099/jgv.0.001075
   PubMed Web of Science ®Google Scholar
• Sufiawati I, Tugizov SM. HIV-associated disruption of tight and adherens junctions of oral epithelial cells facilitates HSV-1 infection and spread. PLoS One. 2014;9(2). doi:10.1371/journal.pone.0088803
   PubMed Web of Science ®Google Scholar
• Zaongo SD, Ouyang J, Isnard S, et al. Candida albicans can foster gut dysbiosis and systemic inflammation during HIV infection. Gut Microbes. 2023;15(1). doi:10.1080/19490976.2023.2167171
   PubMed Web of Science ®Google Scholar
• Nazli A, Chan O, Dobson-Belaire WN, et al. Exposure to HIV-1 directly impairs mucosal epithelial barrier integrity allowing microbial translocation. PLoS Pathog. 2010;6(4):1–20. doi:10.1371/journal.ppat.1000852
   Web of Science ®Google Scholar
• Zevin AS, McKinnon L, Burgener A, Klatt NR. Microbial translocation and microbiome dsybiosis in HIV- associated immune activation. Curr Opin HIV AIDS. 2016;11(2):182–190. doi:10.1053/j.gastro.2016.08.014.CagY
   PubMed Web of Science ®Google Scholar
• Goulart LS, Souza WW, Vieira CA, et al. Oral colonization by Candida species in HIV-positive patients: association and antifungal susceptibility study. Einstein. 2018;16(3):eAO4224. doi:10.1590/S1679-45082018AO4224
   PubMed Web of Science ®Google Scholar
• Ribeiro Ribeiro AL, De Alencar Menezes TO, De Melo Alves-Junior S, De Menezes SAF, Marques-Da-Silva SH, Rosário Vallinoto AC. Oral carriage of Candida species in HIV-infected patients during highly active antiretroviral therapy (HAART) in Belém, Brazil. Oral Surg Oral Med Oral Pathol Oral Radiol. 2015;120(1):29–33. doi:10.1016/j.oooo.2015.03.008
   PubMed Web of Science ®Google Scholar
• Hirata CHW. Oral manifestations in AIDS. Braz J Otorhinolaryngol. 2015;81(2):120–123. doi:10.1016/j.bjorl.2014.12.001
   PubMed Web of Science ®Google Scholar
• Hamza OJM, Matee MIN, Moshi MJ, et al. Species distribution and in vitro antifungal susceptibility of oral yeast isolates from Tanzanian HIV-infected patients with primary and recurrent oropharyngeal candidiasis. BMC Microbiol. 2008;8:1–9. doi:10.1186/1471-2180-8-135
   PubMed Web of Science ®Google Scholar
• Egierska DM, Perszke M, Grzelewski A, et al. Oral diseases in patients infected with HIV. J Educ Heal Sport. 2022;12(8):556–571. doi:10.12775/JEHS.2022.12.08.059
   Google Scholar
• Peña DER, Innocentini LMAR, Saraiva MCP, Lourenço AG, Motta ACF. Oral candidiasis prevalence in human immunodeficiency virus-1 and pulmonary tuberculosis coinfection: a systematic review and meta-analysis. Microb Pathog. 2021;150:1–6. doi:10.1016/j.micpath.2020.104720
   Web of Science ®Google Scholar
• Patil S, Majumdar B, Sarode SC, Sarode GS, Awan KH. Oropharyngeal candidosis in HIV-infected patients-an update. Front Microbiol. 2018;9:1–9. doi:10.3389/fmicb.2018.00980
   PubMed Web of Science ®Google Scholar
• Frimpong P, Amponsah EK, Abebrese J, Kim SM, Kim SM. Oral manifestations and their correlation to baseline CD4 count of HIV/AIDS patients in Ghana. J Korean Assoc Oral Maxillofac Surg. 2017;4:29–36. doi:10.5125/jkaoms.2017.43.1.29
   Google Scholar
• Shekatkar M, Kheur S, Gupta AA, et al. Oral candidiasis in human immunodeficiency virus-infected patients under highly active antiretroviral therapy. Disease-a-Month. 2021;67(9):101169. doi:10.1016/j.disamonth.2021.101169
   PubMed Web of Science ®Google Scholar
• Ghom AG, Ghom SA. Textbook of Oral Medicine. 3th ed. Jaypee Brothers Medical Publishers; 2014. doi:10.5005/jp/books/12631_48
   Google Scholar
• Sachdeva S. Oral thrush in an infant: a case report with treatment modalities. Pediatr Dent Care. 2016;1:1–3. doi:10.4172/2573-444X.1000106
   Google Scholar
• Mowla MR, Manchur MA, Islam AQMS, Maurer T. Cutaneous manifestations of HIV/AIDS in the Era of highly active antiretroviral therapy: evidence from Bangladesh. Int J Dermatology Venereol. 2022;5(1):8–14. doi:10.1097/JD9.0000000000000205
   Google Scholar
• Glick M, Greenberg M, Lockhart P, et al. Burket’s Oral Medicine. Vol. 4. 13th ed. John Wiley & Sons Inc; 2021.
   Google Scholar
• Stephen BD, Babatunde AA, Nicaise N, Fati MI, Patrick SD, Ahmad TA. Immunological and clinical assessment of adult HIV patients following switch to second-line antiretroviral regimen in a large HIV program in North-central Nigeria. J AIDS HIV Res. 2017;9(5):106–116. doi:10.5897/jahr2017.0416
   Google Scholar
• Chinnappan JA, Lakshmipriya N, Umadevi U, et al. Distribution of candida species with antifungal susceptibility isolated from oral thrush in people living with HIV/AIDS and its correlation with CD4 count. Curr Res HIV AIDS. 2020;04(01):2–5. doi:10.29011/2575-7105.100121
   Google Scholar
• Shah Jigna S, Tarsariya Vivek M, Barot Kaushik S, et al. Oral health related quality of life in HIV patients Shah. J Adv Med Dent Sci Res. 2021;9(6):159–164.
   Google Scholar
• Umeizudike KA, Osagbemiro BB, Daramola OO, Adeyemo TA. Oral health related quality of life among HIV positive patients attending two HIV outpatient clinics in Nigeria-a cross sectional study. Afr Health Sci. 2021;21(2):566–575. doi:10.4314/ahs.v21i2.11
   PubMed Web of Science ®Google Scholar
• Silverman S. Essentials of Oral Medicine. BC Decker Inc; 2002.
   Google Scholar
• Jain P, Sontakke P, Anup N, Sikka M, Biswas G, Shravani G. Oral health-related quality of life among HIV patients at antiretroviral therapy center government hospital, Jaipur. J Indian Assoc Public Heal Dent. 2015;13(2):148. doi:10.4103/2319-5932.159051
   Google Scholar
• Sufiawati I, Sasanti H. Herpes labialis and oral candidiasis in HIV-infected intravenous drug users with poor hematologic status. Padjadjaran J Dent. 2008;20(3):179–185. doi:10.24198/pjd.vol20no3.14125
   Google Scholar
• Sufiawati I, Sasanti H, Djauzi S. Correlation between saliva IgA level and T cell CD4+ in HIV/AIDS patients. Padjadjaran J Dent. 2007;19(2):67–72. doi:10.24198/pjd.vol19no2.14169
   Google Scholar
• Indrastiti RK, Wardhany II, Soegyanto AI. Oral manifestations of HIV: can they be an indicator of disease severity? (A systematic review). Oral Dis. 2020;26(S1):133–136. doi:10.1111/odi.13394
   PubMedGoogle Scholar
• Bajomo AS, Ayo-Yusuf OA, Rudolph MJ, Tsotsi NM. Impact of oral lesions among South African adults with HIV/AIDS on oral health-related quality of life. J Dent Sci. 2013;8(4):412–417. doi:10.1016/j.jds.2013.04.011
   Web of Science ®Google Scholar
• Mohamed N, Saddki N, Yusoff A, Mat Jelani A. Association among oral symptoms, oral health-related quality of life, and health-related quality of life in a sample of adults living with HIV/AIDS in Malaysia. BMC Oral Health. 2017;17(1):1–11. doi:10.1186/s12903-017-0409-y
   Google Scholar